Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LowASA-PCI: Very Low-dose vs Standard Aspirin in Elderly ACS Patients
NCT06254391Phase 2Recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in acute coronary syndrome (ACS), myocardial infarction (MI), sponsored by Medical University of Warsaw. Started Jul 2023; status: recruiting.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT06254391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06254391.